Title: Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
Journal: Journal of medicinal chemistry 20120412
Title: Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
Journal: Bioorganic & medicinal chemistry 20120215
Title: Label-free detection of protein binding with multisine SPR microchips.
Journal: Lab on a chip 20111221
Title: Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
Journal: Bioorganic & medicinal chemistry 20110815
Title: A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
Journal: Bioorganic & medicinal chemistry 20110201
Title: Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
Journal: Bioorganic & medicinal chemistry letters 20110115
Title: 3-(6-Bromo-4-oxo-4H-chromen-3-yl)-3,4-dihydro-2H-1,2,4-benzothia-diazine-1,1-dione.
Journal: Acta crystallographica. Section E, Structure reports online 20101201
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: 3-(6-Fluoro-4-oxo-4H-chromen-3-yl)-3,4-dihydro-2H-1,2,4-benzothia-diazine-1,1-dione.
Journal: Acta crystallographica. Section E, Structure reports online 20101101
Title: Syntheses and evaluation of anticonvulsant profile and teratogenicity of novel amide derivatives of branched aliphatic carboxylic acids with 4-aminobenzensulfonamide.
Journal: Journal of medicinal chemistry 20100527
Title: 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20100515
Title: Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
Journal: Journal of medicinal chemistry 20100311
Title: Gene expression signature-based screening identifies new broadly effective influenza a antivirals.
Journal: PloS one 20100101
Title: Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
Journal: Bioorganic & medicinal chemistry letters 20091201
Title: Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
Journal: Bioorganic & medicinal chemistry 20090715
Title: Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
Journal: Bioorganic & medicinal chemistry 20090701
Title: Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Journal: Journal of medicinal chemistry 20090514
Title: Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
Journal: Journal of medicinal chemistry 20090423
Title: A novel class of allosteric modulators of AMPA/Kainate receptors.
Journal: Bioorganic & medicinal chemistry letters 20090215
Title: Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
Journal: Bioorganic & medicinal chemistry 20090201
Title: Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.
Journal: Bioorganic & medicinal chemistry 20080315
Title: Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Journal: Bioorganic & medicinal chemistry 20071201
Title: Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20070701
Title: Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Journal: Journal of medicinal chemistry 20070125
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Journal: Bioorganic & medicinal chemistry letters 20060415
Title: QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.
Journal: Bioorganic & medicinal chemistry letters 20060401
Title: Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Journal: Journal of medicinal chemistry 20060323
Title: Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
Journal: Journal of medicinal chemistry 20051201
Title: Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20050901
Title: Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Journal: Bioorganic & medicinal chemistry letters 20050215
Title: Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20050215
Title: Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Journal: Bioorganic & medicinal chemistry letters 20041115
Title: Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
Journal: Bioorganic & medicinal chemistry letters 20040716
Title: Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20040621
Title: Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
Journal: Bioorganic & medicinal chemistry letters 20030324
Title: Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
Journal: Journal of medicinal chemistry 20020328
Title: Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.
Journal: Bioorganic & medicinal chemistry letters 20010226
Title: Vullo D, et al. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1005-9.